Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Dev Regulatory News (FDEV)

Share Price Information for Frontier Dev (FDEV)

Share Price is delayed by 15 minutes
Get Live Data
457.50    -4.00 (-0.87%)
Bid:
452.00
Ask:
463.50
Spread: 11.50 (2.544%)
Market Cap: £158.91m
FDEV Live PriceLast checked at - London Stock Exchange

Intraday Frontier Dev Share Chart

EBT and Director Dealings

9 Dec 2016 14:07

RNS Number : 4817R
Frontier Developments PLC
09 December 2016
 

9 December 2016

Frontier Developments plc

(the "Company")

 

EBT and Director Dealings

 

 

Frontier Developments plc (AIM: FDEV, "Frontier", the "Group"), a leading developer of video games, announces the following dealing:

 

Employee Benefit Trust Dealings

 

The Company was notified today by Estera Trust (Jersey) Limited, the trustee of the Frontier Developments plc Employee Share Ownership Plan Trust (the "EBT"), that the EBT transferred 100,500 shares to meet employee share option awards at an average exercise price of 0.891 pence per Ordinary Share

 

Following this exercise of options, 25,552 were repurchased by the EBT at 205.0 pence per share to meet the exercise price and individuals' associated tax liabilities. The balances of 74,948 shares are to be transferred to employees.

 

Following this transaction, the EBT is interested in 143,452 Ordinary Shares, representing 0.4 per cent of the Company's total issued share capital.

 

The EBT is a discretionary trust for the benefit of employees of the Company and its subsidiaries, who have been granted share options. The Executive Directors of the Company are included in the class of potential beneficiaries of the EBT and are deemed to be interested in those shares and the dealings thereof.

 

Director Dealings

 

Jonathan Watts, Chief Creative Officer exercised share options of 22,000 at an exercise price of 0.89 pence per Ordinary Share.

 

Following the exercise of these options Mr. Watts sold 9,552 Ordinary Shares at a price of 205.0 pence per Ordinary Share to meet the exercise price and associated tax liabilities.

 

Following the options exercise and related sale the interests of Mr. Watts are as follows:

 

Director

Number of Ordinary Shares prior to transaction

Number of Ordinary Shares post transaction

Total interest in Ordinary Shares as % of issued share capital

Jonathan Watts

55,390

67,838

0.2%

 

 

 

Enquiries:

 

Frontier Developments

+44 (0)1223 394 300

David Braben, CEO

David Walsh, COO

 

 

 

Numis - Nomad and Joint Broker

+44 (0)20 7260 1000

Simon Willis / Toby Adcock / Jamie Lillywhite (Nomad)

 

 

 

Finncap

+44 (0) 207 220 0500

Matt Goode/Giles Rolls

 

 

 

Tulchan Communications

+44 (0) 207 353 4200

James Macey White/Matt Low

 

 

About Frontier Developments plc

Frontier Developments plc, listed on the AIM stock market (AIM: FDEV), is a leading independent game developer founded in 1994 by David Braben, co-author of the seminal 'Elite' game. Based in Cambridge, Frontier uses its proprietary 'COBRA' game development technology to create innovative games across videogame consoles, computers, smartphones and tablets.

www.frontier.co.uk 

Frontier Developments plc

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Jonathan Watts

2.

Reason for the notification

a)

Position/status: Chief Creative Officer

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: n/a

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary shares of 0.05p each.

Identification code: GB00BBT32N39

b)

Nature of the transaction: Acquisition of shares linked to an exercise under a share option programme

c)

Price(s) and volume(s):

Price(s)

Volume(s)

0.89p

12,448

d)

Aggregated information:

· Aggregated volume: 12,448

· Price: 0.89p

e)

Date of the transaction: 2016-12-09

f)

Place of the transaction: Outside a trading venue

 

Frontier Developments plc

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Jonathan Watts

2.

Reason for the notification

a)

Position/status: Chief Creative Officer

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: n/a

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary shares of 0.05p each.

Identification code: GB00BBT32N39

b)

Nature of the transaction: Sale of shares

c)

Price(s) and volume(s):

Price(s)

Volume(s)

205 p

9,552

d)

Aggregated information:

· Aggregated volume: 9,552

· Price: 205p

e)

Date of the transaction: 2016-12-09

f)

Place of the transaction: Outside a trading venue

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUKRSRNNAURAA
Date   Source Headline
1st Jun 202612:05 pmRNSEBT Share Purchase
28th May 20262:30 pmRNS-RPlanet Zoo 2 Announced
22nd May 202611:26 amRNS-RWarhammer 40,000: Chaos Gate – Deathwatch Revealed
22nd May 20269:16 amRNSHolding(s) in Company
19th May 20265:47 pmRNSHolding(s) in Company
18th May 202610:48 amRNSEBT Share Purchase
12th May 20267:00 amRNSTrading Update - FY26 Revenue & Profit Upgraded
23rd Apr 20267:00 amRNSCompletion of Share Buyback Programme
23rd Apr 20267:00 amRNSDirector/PDMR Shareholding
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 202611:05 amRNSHolding(s) in Company
22nd Apr 20267:00 amRNSDirector/PDMR Shareholding
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
14th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSDirector/PDMR Shareholding
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.